Announcing our newest Management member

Announcing our newest Management member

02 Apr 2019

Karen Tornøe joined Cytovac the 1st of April 2019 as Chief Medical Officer.

Karen holds a MD and Ph.D. degree from the University of Copenhagen. She has a broad clinical experience as MD and a long experience within clinical drug development and regulatory strategies from employments at the Danish Medicines Agency and Novo Nordisk.

Karen will be our medical specialist and have the over-all responsibility of our clinical development.

We look very much forward to working together with Karen as we expand our pipeline with Triple Negative Breast Cancer in 2019.

Error, cant find that post.